|Mr. Thomas J. Shaw||Founder, Chairman, Pres & CEO||1.82M||1.35M||66|
|Mr. Douglas W. Cowan||VP, CFO, Treasurer, Principal Accounting Officer & Director||290k||N/A||74|
|Ms. Michele M. Larios Esq.||VP, Gen. Counsel & Sec.||350k||N/A||51|
|Ms. Kathryn M. Duesman RN||Exec. Director of Global Health||184.75k||N/A||54|
|Mr. Russell B. Kuhlman||VP of Sales Devel.||153.52k||N/A||63|
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare industry in the United States and internationally. Its principal products comprise VanishPoint 0.5mL insulin syringes; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; EasyPoint needles; VanishPoint blood collection tube holders; VanishPoint IV safety catheters; small diameter tube adapters; allergy trays; Patient Safe syringes; Patient Safe Luer caps; and VanishPoint blood collection sets, as well as VanishPoint autodisable syringes. The company is also developing retractable needles and syringes, glass syringes, dental syringes, IV catheter introducers, and blood collection sets. It serves healthcare providers, such as acute care hospitals, alternate care facilities, doctors offices, clinics, emergency centers, surgical centers, long-term care facilities, veterans administration facilities, military organizations, public health facilities, and prisons. The company distributes its products through general line and specialty distributors, as well as through international distributors; and a direct marketing network. Retractable Technologies, Inc. was founded in 1994 and is headquartered in Little Elm, Texas.
Retractable Technologies, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.